Evidence map›Paper›PMID 40552178›Full record

ArticleFrontiers in medicine2025

A study on predicting impaired fasting glucose risk in Chinese adults based on individual characteristics.

Yijun Lin, Wenxu Wu, Xiaoyan Liang, Liping Zhou, Gan Li, Cuiling Kang, Wuzhen Li, Chunyi Huang, Feng Tian

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yijun Lin *Department of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Wenxu Wu *Department of Health Examination Center, The First People's Hospital of Nanning, Nanning, China.
Xiaoyan LiangDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Liping ZhouDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Gan LiDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Cuiling KangDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Wuzhen LiSchool of Politics and Public Administration, South China Normal University, Guangzhou, Guangdong, China.
Chunyi HuangDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
Feng TianDepartment of Health Management Centre, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to develop a nomogram for early detection of impaired fasting glucose (IFG), predicting the 5-year risk in Chinese adults due to its link to various diseases. Materials and methods: This retrospective cohort study included 28,875 participants without IFG at baseline, randomly divided them to a training set and a validation set. We developed four predictive models-LASSO, full, stepwise, and MFP-ultimately selecting the LASSO model for nomogram development due to its simplicity and predictive performance. Four prediction model performance was assessed through ROC analysis, calibration curves, and decision curve analysis, with external validation using Shunde Hospital ( Results: We developed a nomogram to predict the risk of IFG by incorporating parameters including age, body mass index (BMI), systolic blood pressure (SBP), fasting plasma glucose (FPG), and triglycerides (TG), which demonstrated performance with AUCs of 0.8167 and 0.8155 in the training and validation set, respectively. External validation achieved AUC 0.9665 (Shunde Hospital dataset) and 0.9171 (NHANES). Conclusions: Our nomogram provides a personalized, validated approach for assessing 5-year IFG risk in Chinese adults, offering a practical screening tool for primary healthcare and resource-constrained environments.

Indexed as

impaired fasting glucoseLASSOnomogramprediction performancerisk score

Identifiers

PMID40552178
PMCPMC12183226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.